Among those, miR-152-3p is described as targeting mTOR, PI3K, and MAPK pathways in solid tumors22–24, whereas miR-503-5p, and miR-29c-3p were identified as PI3K signaling regulators in lung and bladder cancer, respectively25,26. The gene discussed is MTOR; the disease is urinary bladder carcinoma.